Global Thrombectomy Devices Market 2016-2020

  • ID: 4013341
  • Report
  • Region: Global
  • 91 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • AngioDynamics
  • Boston Scientific
  • Edwards Lifesciences
  • Minnetronix
  • Penumbra
  • MORE
About Thrombectomy Devices
Over the years, majority of the minimally invasive cardiovascular surgeries have been increasingly using atherectomy and thrombectomy devices to increase the success rate of surgeries and reduce the procedure and recovery time. Atherectomy devices are primarily used to clear blood vessels that have been occluded by fat accumulation (atherosclerosis plaque). Thrombectomy devices, on the other hand, are used to extract, excise, or disrupt blood clots. They use a variety of methods to safely remove emboli in any part of the body. The global thrombectomy devices market is witnessing continuous technological developments and innovations.

Analysts forecast the global thrombectomy devices market to grow at a CAGR of 5.73% during the period 2016-2020.

Covered in This Report:
The report covers the present scenario and the growth prospects of the global thrombectomy devices market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of thrombectomy products provided by various vendors in the market.

The Market is Divided into the Following Segments Based on Geography:
- Americas
- APAC
- EMEA

Global Thrombectomy Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors:
- Boston Scientific
- Medtronic
- Teleflex
- DePuy Synthes

Other Prominent Vendors:
- Abbott Laboratories
- Acandis
- AngioDynamics
- Argon Medical Devices
- Edwards Lifesciences
- Minnetronix
- NexGen Medical Systems
- Penumbra
- Reverse Medical
- Stryker
- Terumo
- Vascular Solutions

Market Drivers:
- Rise in prevalence of cardiovascular and cerebrovascular diseases
- For a full, detailed list, view the full report

Market challenges:
- Lack of product differentiation
- For a full, detailed list, view the full report

Market Trends:
- Technological advancements with the advent of laser & UV radiation
- For a full, detailed list, view the full report

Key Questions Answered in This Report:
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • AngioDynamics
  • Boston Scientific
  • Edwards Lifesciences
  • Minnetronix
  • Penumbra
  • MORE
Part 01: Executive summary
  • Highlights
Part 02: Scope of the report
  • Market overview
  • Top-vendor offerings
Part 03: Market research methodology
  • Research methodology
  • Economic indicators
Part 04: Introduction
  • Key market highlights
Part 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
Part 06: Market segmentation by product
  • Mechanical thrombectomy devices
  • Aspiration thrombectomy devices
  • Rheolytic thrombectomy devices
Part 07: Market segmentation by indication
  • Market overview
Part 08: Market segmentation by end-users
  • Global thrombectomy devices market by hospitals
  • Global thrombectomy devices market by ambulatory surgical centers
Part 09: Geographical segmentation
  • Thrombectomy devices market in Americas
  • Thrombectomy devices market in EMEA
  • Thrombectomy devices market in APAC
Part 10: Market drivers
  • Rise in prevalence of cardiovascular and cerebrovascular diseases
  • Acquisition of small specialized hospitals by tier-1 hospitals
  • Increasing product approvals and patents
Part 11: Impact of drivers

Part 12: Market challenges
  • Lack of product differentiation
  • Increase in product recalls
  • Adverse effects of thrombectomy devices
Part 13: Impact of drivers and challenges

Part 14: Market trends
  • Technological advancements with the advent of laser & UV radiation
  • Increasing demand for minimally invasive surgery
  • Strategic acquisition of business segments
Part 15: Vendor landscape
  • Competitive scenario
Part 16: Key vendor analysis
  • Boston Scientific
  • Medtronic
  • Teleflex
  • DePuy Synthes
  • Key news
  • Other prominent vendors
Part 17: Appendix
  • List of abbreviations
Part 18: About the Author

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global thrombectomy device market: Overview
Exhibit 03: Market factors impacting growth, drivers, and challenges
Exhibit 04: Global thrombectomy devices market 2015-2020 ($ millions)
Exhibit 05: Five forces analysis
Exhibit 06: Global thrombectomy devices market by product 2015
Exhibit 07: Mechanical thrombectomy devices: Market overview
Exhibit 08: Factors affecting global mechanical thrombectomy devices market
Exhibit 09: Global mechanical thrombectomy devices market 2015-2020 ($ millions)
Exhibit 10: Aspiration thrombectomy devices: Market overview
Exhibit 11: Factors affecting global aspiration thrombectomy devices market
Exhibit 12: Global aspiration thrombectomy devices market 2015-2020 ($ millions)
Exhibit 13: Rheolytic thrombectomy devices: Market overview
Exhibit 14: Factors affecting global rheolytic thrombectomy devices
Exhibit 15: Global rheolytic thrombectomy devices market 2015-2020 ($ millions)
Exhibit 16: Global thrombectomy devices: Market segmentation
Exhibit 17: Global nucleic acid testing market by indication 2015
Exhibit 18: Global thrombectomy devices by end-users 2015-2020
Exhibit 19: Thrombectomy devices market: ASCs in Americas
Exhibit 20: Number of licensed ASCs in US
Exhibit 21: Thrombectomy devices market: ASCs in EMEA
Exhibit 22: Thrombectomy devices market: ASCs in APAC
Exhibit 23: Global thrombectomy devices market by geography in 2015 and 2020 ($ millions)
Exhibit 24: Global thrombectomy devices market percentage share by geography 2015
Exhibit 25: Americas: Market overview of thrombectomy devices
Exhibit 26: Thrombectomy devices market in Americas 2015-2020 ($ millions)
Exhibit 27: Americas: Market metrics in various countries
Exhibit 28: Key takeaway: Thrombectomy devices market in US
Exhibit 29: EMEA: Market overview of thrombectomy devices
Exhibit 30: Thrombectomy devices market in EMEA 2015-2020 ($ millions)
Exhibit 31: EMEA: Market metrics in various countries
Exhibit 32: Key takeaway: Thrombectomy devices market in UK
Exhibit 33: APAC: Market overview of thrombectomy devices
Exhibit 34: Thrombectomy devices market in APAC 2015-2020 ($ millions)
Exhibit 35: APAC: Market metrics in various countries
Exhibit 36: Key takeaway: Thrombectomy devices market in India
Exhibit 37: Total number of hospitals in US
Exhibit 38: Impact of drivers
Exhibit 39: Products and their types
Exhibit 40: Product recalls
Exhibit 41: Adverse effects of thrombectomy devices
Exhibit 42: Stent retriever trial studies with success rate
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Benefits of technological advancement
Exhibit 45: Market metrics for laser based device
Exhibit 46: Market dynamics for minimally invasive procedures in thrombectomy devices market
Exhibit 47: Market enablers and risks associated with procedures
Exhibit 48: Strategic acquisitions of thrombectomy devices
Exhibit 49: Competitive structure analysis of global thrombectomy devices market 2015
Exhibit 50: Competitive landscape analysis of global thrombectomy devices market
Exhibit 51: Market penetration of various global thrombectomy device manufacturers (2015)
Exhibit 52: Strategic success factors of companies in global thrombectomy devices market
Exhibit 53: Market share for global thrombectomy devices market 2015
Exhibit 54: Boston Scientific: Strength analysis
Exhibit 55: Boston Scientific: Strategy assessment
Exhibit 56: Boston Scientific: Opportunity assessment
Exhibit 57: Medtronic: Strength analysis
Exhibit 58: Medtronic: Strategy assessment
Exhibit 59: Medtronic: Opportunity assessment
Exhibit 60: Teleflex: Strength analysis
Exhibit 61: Teleflex: Strategy assessment
Exhibit 62: Teleflex: Opportunity assessment
Exhibit 63: DePuy Synthes: Strength analysis
Exhibit 64: Depuy Synthes: Strategy assessment
Exhibit 65: DePuy Synthes: Opportunity assessment
Exhibit 66: Other prominent vendors: Global thrombectomy devices market
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • AngioDynamics
  • Boston Scientific
  • Edwards Lifesciences
  • Minnetronix
  • Penumbra
  • MORE
Global Thrombectomy Devices Market 2016-2020

Key players in the global thrombectomy devices market: Boston Scientific, Medtronic, Teleflex, and DePuy Synthes.

Other Prominent Vendors in the market are: Abbott Laboratories, Acandis, AngioDynamics, Argon Medical Devices, Edwards Lifesciences, Minnetronix, NexGen Medical Systems, Penumbra, Reverse Medical, Stryker, Terumo, and Vascular Solutions.

Commenting on the report, an analyst from the team said: “The latest trend gaining momentum in the market is technological advancements with the advent of laser & UV radiation. With the advent of laser and ultra-violet (UV) radiation technology, the dissolving of blood clots has become easier. The use of laser thrombectomy has eliminated the need for mechanical thrombus removal. Pulsed UV excimer laser light at 380nm frequency can help in the vaporization of thrombus and suppressing the aggregation of platelets.”

According to the report, one of the major drivers for this market is rise in prevalence of cardiovascular and cerebrovascular diseases. the rise in prevalent cases of cardiovascular and cerebrovascular diseases is driving the market growth, with the increased use of thrombectomy devices for the removal of blood clots. Some of the common cardiovascular diseases where blood clots occur are coronary heart diseases and peripheral vascular diseases.

Further, the report states that one of the major factors hindering the growth of this market is lack of product differentiation. Vendors are currently finding it difficult to remain competitive in the market because of the lack of product differentiation. Since the features and functionalities of various products are similar in nature, most healthcare centers and surgeons tend to opt for products based on familiarity with a specific brand name. Hence, it is critical for manufacturers to develop a technologically-advanced product line to achieve product differentiation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Boston Scientific
  • Medtronic
  • Teleflex
  • DePuy Synthes
  • Abbott Laboratories
  • Acandis
  • AngioDynamics
  • Argon Medical Devices
  • Edwards Lifesciences
  • Minnetronix
  • NexGen Medical Systems
  • Penumbra
  • Reverse Medical
  • Stryker
  • Terumo
  • Vascular Solutions.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll